Michele Fusaroli
Bologna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Reply to "A Comment about AI Methods that May Help Advance Pharmacovigilance".
Journal: Clinical pharmacology and therapeutics
Published: April 17, 2026
Neutropenia and infectious events during off-label treatment with venetoclax in children with malignant disease: a pharmacovigilance analysis of FDA adverse event reporting system reports.
Journal: Annals of hematology
Published: November 18, 2025
The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence-Based Medicine.
Journal: Clinical pharmacology and therapeutics
Published: November 04, 2025
Correction: Charting and Sidestepping the Pitfalls of Disproportionality Analysis.
Journal: Drug safety
Published: October 15, 2025
International Medicinal Product Information Documents: A Quantitative Content Analysis of Instructions for Preventing, Mitigating, and Monitoring Adverse Drug Reactions.
Journal: Drug safety
Published: October 10, 2025
VigiBase: Resource Profile Update with a Summary of Global Patterns and Trends in Adverse Event Reports for Medicines and Vaccines.
Journal: Drug safety
Published: September 12, 2025
Ivabradine, atrial fibrillation and stroke: a combined meta-analysis and FAERS disproportionality analysis.
Journal: Frontiers in pharmacology
Published: May 31, 2025
Charting and Sidestepping the Pitfalls of Disproportionality Analysis.
Journal: Drug safety
Published: March 31, 2025
Characterizing post-mortem blood concentrations in methadone-related deaths.
Journal: International journal of legal medicine
Published: February 28, 2025
Are Causal Statements Reported in Pharmacovigilance Disproportionality Analyses Using Individual Case Safety Reports Exaggerated in Related Citations? A Meta-epidemiological Study.
Journal: Drug safety
Published: January 27, 2025
Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase.
Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase.
Journal: Journal for immunotherapy of cancer
Published: October 11, 2024
The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline.
Journal: Frontiers in pharmacology
Published: August 30, 2024
Last Updated: 09/26/2026